DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MONTELUKAST SODIUM

« Back to Dashboard

Clinical Trials for Montelukast Sodium

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000577	Asthma Clinical Research Network (ACRN)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00000622	Childhood Asthma Research and Education (CARE) Network	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	The purpose of this study is to evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.
NCT00092105	Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)	Completed	Merck Sharp & Dohme Corp.	Phase 3	The purpose of this study is to determine the protective effect of an approved medication on asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure to cats.
NCT00092989	Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)	Completed	Merck Sharp & Dohme Corp.	Phase 3	The purpose of this study is to evaluate improved results of treatment for patients entering an emergency department with asthma attacks when given an investigational IV administration of an approved drug (MK-0476, montelukast sodium) in addition to approved standard treatment.

Clinical Trial Conditions for Montelukast Sodium

Condition Name

Condition Name for Montelukast Sodium
Intervention	Trials
Asthma	20
Healthy	11
Allergic Rhinitis	3
Seasonal Allergic Rhinitis	3

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Montelukast Sodium
Intervention	Trials
Asthma	15
Rhinitis	10
Rhinitis, Allergic	9
Lung Diseases	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Montelukast Sodium

Trials by Country

Trials by Country for Montelukast Sodium
Location	Trials
United States	30
India	12
Korea, Republic of	5
Poland	3
China	3

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Montelukast Sodium
Location	Trials
North Dakota	4
Missouri	3
California	3
Wisconsin	3
New Jersey	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Montelukast Sodium

Clinical Trial Phase

Clinical Trial Phase for Montelukast Sodium
Clinical Trial Phase	Trials
Phase 4	11
Phase 3	11
Phase 2	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Montelukast Sodium
Clinical Trial Phase	Trials
Completed	44
Recruiting	3
Unknown status	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Montelukast Sodium

Sponsor Name

Sponsor Name for Montelukast Sodium
Sponsor	Trials
Merck Sharp & Dohme Corp.	13
Dr. Reddy's Laboratories Limited	6
Torrent Pharmaceuticals Limited	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Montelukast Sodium
Sponsor	Trials
Industry	37
Other	16
NIH	4

Export unavailable in trial.
Subscribe for complete access.